Riskpilot← Back to searchSign inGet full accessNORAMIX LIAMYRANE 10 AS
ASActiveOrg 988456225Liamyrane 13, 5132 NyborgRental and operating of own or leased real estate · NACE 6820Est. 20050 employees
Revenue 2024
NOK 6,9M
+1% vs 2023
EBITDA margin
80.5%
+9% vs 2023
Equity ratio
39.2%
Financial strength
Net profit 2024
NOK 3,2M
+11% vs 2023
| Revenue | NOK 6,9M | +1% |
| EBITDA | NOK 5,5M | +9% |
| Net profit | NOK 3,2M | +11% |
| Total assets | NOK 25,7M | +4% |
| Equity | NOK 10,1M | +10% |
| Employees | 0 | — |
Legal name
NORAMIX LIAMYRANE 10 AS
Org number
988456225
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
18. juli 2005
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å drive utleie av fast eiendom samt kjøp og salg av fast eiendom. Videre skal selskapet kunne kjøpe andeler i andre selskaper.
Address
Liamyrane 13, 5132 Nyborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 928 | 5 825 | 6 808 | 6 760 | 6 859 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 3 522 | 4 230 | 4 182 | 5 066 | 5 523 |
| Depreciation & amort. | −604 | −604 | −642 | −663 | −705 |
| EBIT | 2 918 | 3 626 | 3 541 | 4 403 | 4 819 |
| Net financials | −690 | −635 | −527 | −739 | −768 |
| Profit before tax | 2 228 | 2 991 | 3 014 | 3 664 | 4 051 |
| Tax | 490 | 658 | 663 | 806 | 891 |
| Net profit | 1 738 | 2 333 | 2 351 | 2 858 | 3 160 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 538 | 26 134 | 25 354 | 24 715 | 25 736 |
| Equity | 6 633 | 8 966 | 9 095 | 9 169 | 10 095 |
| Long-term debt | 967 | 1 015 | 3 137 | 6 322 | 1 334 |
| Short-term debt | 18 938 | 16 152 | 13 121 | 9 224 | 14 307 |
| Total debt | 19 905 | 17 167 | 16 259 | 15 546 | 15 641 |
EBITDA margin
80.5%
This company
15.8%
Market median
+409% vs market
20202024
Equity ratio
39.2%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
31.3%
This company
18.4%
Market median
+70% vs market
20202024
Net profit margin
46.1%
This company
8.1%
Market median
+469% vs market
20202024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20202024
Debt / equity
1.55×
This company
0.62×
Market median
-150% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RE Deputy Member | Deputy Member | 2012 |
KR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
TE Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Noramix Invest AsNoramix Eiendom Holding AsNoramix Eiendom Ii As
NORAMIX LIAMYRANE 10 AS (this company)Board members of NORAMIX LIAMYRANE 10 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Espeseth Rasmussen | Chief Executive Officer | 0 companies |
| Randi Elisabeth Kalvik Rasamanickam | Deputy Member | 0 companies |
| Keerthivarman Rasamanickam | Chief Executive Officer | 0 companies |